Oct. 6, 2006 — Lumera Corp., a Bothell, Wash., provider of light applied nanotechnology, announced an expanded collaboration agreement with the Institute for Systems Biology, a non-profit research institute dedicated to the study and application of systems biology. The revised collaboration agreement will focus on detection methods for an array of diagnostic biomarkers aimed at various types of cancer.
The announcement extends an agreement between Lumera and the institute announced in February of 2005. ISB was the first academic institution to test Lumera’s ProteomicProcessor.
Since February of 2005, Harvard Medical School and Harvard Institute of Proteomics, Baylor University and the Medical University of South Carolina have joined the institute in beta testing Lumera’s ProteomicProcessor. Lumera says the instrument has evolved as a result of their feedback and the company expects to launch a refined commercial ProteomicProcessor product in January.